# Autologous Stem Cell Transplant for Refractory Crohn's Disease

> **NCT02676622** · PHASE2 · WITHDRAWN · sponsor: **Nationwide Children's Hospital**

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** mobilization of stem cells to prepare for Leukapheresis
- **OTHER:** Leukapheresis- Collection of stem cells
- **DRUG:** Preparative regimen 4-6 weeks after Leukapheresis
- **OTHER:** Stem Cell Transplant
- **DRUG:** Low-dose IL-2 administration

## Key facts

- **NCT ID:** NCT02676622
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI moved to a different institution.
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676622, "Autologous Stem Cell Transplant for Refractory Crohn's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02676622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*